1. Home
  2. AYTU vs ISPO Comparison

AYTU vs ISPO Comparison

Compare AYTU & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • ISPO
  • Stock Information
  • Founded
  • AYTU N/A
  • ISPO 2010
  • Country
  • AYTU United States
  • ISPO United States
  • Employees
  • AYTU N/A
  • ISPO N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • AYTU Health Care
  • ISPO Finance
  • Exchange
  • AYTU Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • AYTU 15.0M
  • ISPO 13.4M
  • IPO Year
  • AYTU N/A
  • ISPO N/A
  • Fundamental
  • Price
  • AYTU $2.28
  • ISPO $3.92
  • Analyst Decision
  • AYTU
  • ISPO Buy
  • Analyst Count
  • AYTU 0
  • ISPO 2
  • Target Price
  • AYTU N/A
  • ISPO $10.50
  • AVG Volume (30 Days)
  • AYTU 30.7K
  • ISPO 34.9K
  • Earning Date
  • AYTU 11-12-2024
  • ISPO 11-04-2024
  • Dividend Yield
  • AYTU N/A
  • ISPO N/A
  • EPS Growth
  • AYTU N/A
  • ISPO N/A
  • EPS
  • AYTU N/A
  • ISPO N/A
  • Revenue
  • AYTU $81,002,000.00
  • ISPO $300,935,000.00
  • Revenue This Year
  • AYTU N/A
  • ISPO N/A
  • Revenue Next Year
  • AYTU N/A
  • ISPO N/A
  • P/E Ratio
  • AYTU N/A
  • ISPO N/A
  • Revenue Growth
  • AYTU N/A
  • ISPO N/A
  • 52 Week Low
  • AYTU $2.20
  • ISPO $3.11
  • 52 Week High
  • AYTU $3.50
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 44.06
  • ISPO 43.78
  • Support Level
  • AYTU $2.25
  • ISPO $3.65
  • Resistance Level
  • AYTU $2.44
  • ISPO $3.97
  • Average True Range (ATR)
  • AYTU 0.13
  • ISPO 0.25
  • MACD
  • AYTU -0.01
  • ISPO -0.04
  • Stochastic Oscillator
  • AYTU 14.17
  • ISPO 16.25

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

About ISPO Inspirato Incorporated

Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.

Share on Social Networks: